Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease: A Randomized Controlled Non-Inferiority Trial

NCT07722650 is registered in ClinicalTrials.gov with Instituto Internacional de Medicina y Terapia (IIMET) as lead sponsor.

NCT NCT07722650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07722650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease: A Randomized Controlled Non-Inferiority Trial
Lead sponsor
Instituto Internacional de Medicina y Terapia (IIMET)
Phase
Not applicable
Overall status
Completed
Start date
January 6, 2025
Completion date
June 30, 2025
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome (des), ocular surface disease